National Science Foundation awarded Auxilium Health, Inc. of Cleveland, OH $275,000 under the SBIR program (Phase I), with work starting 2025-03-01 and running to 2026-02-28. It is the only SBIR or STTR award to Auxilium Health, Inc. in the last two years. Each figure links to the federal record.
The award
| Recipient | Auxilium Health, Inc. (Cleveland, OH) |
|---|---|
| Awarding agency | National Science Foundation |
| Phase | Phase I |
| Amount obligated | $275,000 |
| Period of performance starts | 2025-03-01 |
| Period of performance ends | 2026-02-28 |
| Award number | 2421214 (grant, CFDA 47.084) |
| Assistance listing | 47.084, Technology, Innovation, and Partnerships |
| Place of performance | Alliance, Stark County, OH |
| Signed | 2025-02-13 |
| Recipient registry id (UEI) | W5KRHVSVG2B7 |
Want the whole picture on Auxilium Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Auxilium Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Auxilium Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
An aerogel wound dressing material platform with mechanical fluid management, biofilm prevention, and ph based infection detection properties
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2025-02-13 | New | 000 | $275,000 |
SBIR Phase I: An aerogel wound dressing material platform with mechanical fluid management, biofilm prevention, and ph based infection detection properties -the broader impact/commercial potential of this small business innovation research (SBIR) Phase I project is a novel wound dressing material for improving chronic wound care by mitigating several biological and microbial factors that affect healing. Chronic wounds affect near 50 million patients in developed countries often leading to persistent infections, prolonged inflammation, and increased healthcare costs. Approximately 80% of infections are associated with bacterial biofilms that delay healing and require frequent interventions. Current solutions often rely on reactive infection management and frequent dressing changes. This project proposes a novel wound dressing with optimal porosity to enable oxygen exchange while creating a pathogen barrier, integrated with real-time detection of infection indicated by a rapid color change. The platform offers a potential solution for improving the management of acute wounds, chronic wounds, surgical sites, and burn, with a total estimated $200M annual market. This small business innovation research (SBIR) Phase I project seeks to develop and validate an aerogel-based biomaterial combining fluid management, biofilm prevention, and rapid infection detection properties into a singl ...
From the federal award record.
More on Auxilium Health, Inc.
Auxilium Health, Inc.'s Form D filing
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Auxilium Health, Inc.Look up Auxilium Health, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.